Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Spindle assembly disruption and cancer cell apoptosis with a CLTC-binding compound.

Bond MJ, Bleiler M, Harrison LE, Scocchera EW, Nakanishi M, G-Dayanandan N, Keshipeddy S, Rosenberg DW, Wright DL, Giardina C.

Mol Cancer Res. 2018 May 16. pii: molcanres.0178.2018. doi: 10.1158/1541-7786.MCR-18-0178. [Epub ahead of print]

PMID:
29769406
2.

Cyclooxygenase-1 and -2 Play Contrasting Roles in Listeria-Stimulated Immunity.

Theisen E, McDougal CE, Nakanishi M, Stevenson DM, Amador-Noguez D, Rosenberg DW, Knoll LJ, Sauer JD.

J Immunol. 2018 Jun 1;200(11):3729-3738. doi: 10.4049/jimmunol.1700701. Epub 2018 Apr 20.

PMID:
29678951
3.

Proximal Aberrant Crypt Foci Associate with Synchronous Neoplasia and Are Primed for Neoplastic Progression.

Drew DA, Mo A, Grady JJ, Stevens RG, Levine JB, Brenner BM, Anderson JC, Forouhar F, O'Brien MJ, Devers TJ, Rosenberg DW.

Mol Cancer Res. 2018 Mar;16(3):486-495. doi: 10.1158/1541-7786.MCR-17-0380. Epub 2017 Dec 8.

PMID:
29222172
4.

A novel bioactive derivative of eicosapentaenoic acid (EPA) suppresses intestinal tumor development in ApcΔ14/+ mice.

Nakanishi M, Hanley MP, Zha R, Igarashi Y, Hull MA, Mathias G, Sciavolino F, Grady JJ, Rosenberg DW.

Carcinogenesis. 2018 Mar 8;39(3):429-438. doi: 10.1093/carcin/bgx136.

PMID:
29206907
5.

Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice.

Chang HH, Moro A, Takakura K, Su HY, Mo A, Nakanishi M, Waldron RT, French SW, Dawson DW, Hines OJ, Li G, Go VLW, Sinnett-Smith J, Pandol SJ, Lugea A, Gukovskaya AS, Duff MO, Rosenberg DW, Rozengurt E, Eibl G.

PLoS One. 2017 Sep 8;12(9):e0184455. doi: 10.1371/journal.pone.0184455. eCollection 2017.

6.

Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia.

Hanley MP, Hahn MA, Li AX, Wu X, Lin J, Wang J, Choi AH, Ouyang Z, Fong Y, Pfeifer GP, Devers TJ, Rosenberg DW.

Oncogene. 2017 Aug 31;36(35):5035-5044. doi: 10.1038/onc.2017.130. Epub 2017 May 1.

7.

Dietary Methyl Donor Depletion Suppresses Intestinal Adenoma Development.

Hanley MP, Kadaveru K, Perret C, Giardina C, Rosenberg DW.

Cancer Prev Res (Phila). 2016 Oct;9(10):812-820. Epub 2016 Aug 16.

8.

Targeted Transcriptional Profiling of Microdissected Biopsy Specimens Representing Early Colonic Neoplasia.

Mo A, Jackson S, Devers TJ, Rosenberg DW.

J Cell Biochem. 2016 Dec;117(12):2677-2681. doi: 10.1002/jcb.25644. Epub 2016 Jul 12.

PMID:
27357168
9.

Distinct Transcriptional Changes and Epithelial-Stromal Interactions Are Altered in Early-Stage Colon Cancer Development.

Mo A, Jackson S, Varma K, Carpino A, Giardina C, Devers TJ, Rosenberg DW.

Mol Cancer Res. 2016 Sep;14(9):795-804. doi: 10.1158/1541-7786.MCR-16-0156. Epub 2016 Jun 27.

10.

Effects of Walnut Consumption on Colon Carcinogenesis and Microbial Community Structure.

Nakanishi M, Chen Y, Qendro V, Miyamoto S, Weinstock E, Weinstock GM, Rosenberg DW.

Cancer Prev Res (Phila). 2016 Aug;9(8):692-703. doi: 10.1158/1940-6207.CAPR-16-0026. Epub 2016 May 23.

11.

Erratum to: A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents.

Caspi M, Firsow A, Rajkumar R, Skalka N, Moshkovits I, Munitz A, Pasmanik-Chor M, Greif H, Megiddo D, Kariv R, Rosenberg DW, Rosin-Arbesfeld R.

J Mol Med (Berl). 2016 Apr;94(4):483. doi: 10.1007/s00109-016-1394-3. No abstract available.

PMID:
26897011
12.

A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents.

Caspi M, Firsow A, Rajkumar R, Skalka N, Moshkovitz I, Munitz A, Pasmanik-Chor M, Greif H, Megido D, Kariv R, Rosenberg DW, Rosin-Arbesfeld R.

J Mol Med (Berl). 2016 Apr;94(4):469-82. doi: 10.1007/s00109-015-1364-1. Epub 2015 Dec 1. Erratum in: J Mol Med (Berl). 2016 Apr;94(4):483.

PMID:
26620677
13.

Colorectal polyp prevention by daily aspirin use is abrogated among active smokers.

Drew DA, Goh G, Mo A, Grady JJ, Forouhar F, Egan G, Swede H, Rosenberg DW, Stevens RG, Devers TJ.

Cancer Causes Control. 2016 Jan;27(1):93-103. doi: 10.1007/s10552-015-0686-1. Epub 2015 Oct 28.

PMID:
26510933
14.

One-Carbon Metabolism and Colorectal Cancer: Potential Mechanisms of Chemoprevention.

Hanley MP, Rosenberg DW.

Curr Pharmacol Rep. 2015 Jun;1(3):197-205.

15.

Regulation of VDR Expression in Apc-Mutant Mice, Human Colon Cancers and Adenomas.

Giardina C, Nakanishi M, Khan A, Kuratnik A, Xu W, Brenner B, Rosenberg DW.

Cancer Prev Res (Phila). 2015 May;8(5):387-99. doi: 10.1158/1940-6207.CAPR-14-0371. Epub 2015 Apr 14.

16.

Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection.

Chen JH, Perry CJ, Tsui YC, Staron MM, Parish IA, Dominguez CX, Rosenberg DW, Kaech SM.

Nat Med. 2015 Apr;21(4):327-34. doi: 10.1038/nm.3831. Epub 2015 Mar 23.

17.

Non-cell autonomous effects of targeting inducible PGE2 synthesis during inflammation-associated colon carcinogenesis.

Nakanishi M, Perret C, Meuillet EJ, Rosenberg DW.

Carcinogenesis. 2015 Apr;36(4):478-86. doi: 10.1093/carcin/bgv004. Epub 2015 Jan 29.

18.

A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.

Gillen DL, Meyskens FL, Morgan TR, Zell JA, Carroll R, Benya R, Chen WP, Mo A, Tucker C, Bhattacharya A, Huang Z, Arcilla M, Wong V, Chung J, Gonzalez R, Rodriguez LM, Szabo E, Rosenberg DW, Lipkin SM.

Cancer Prev Res (Phila). 2015 Mar;8(3):222-30. doi: 10.1158/1940-6207.CAPR-14-0148. Epub 2015 Jan 20.

19.

The role of PGE2 in intestinal inflammation and tumorigenesis.

Montrose DC, Nakanishi M, Murphy RC, Zarini S, McAleer JP, Vella AT, Rosenberg DW.

Prostaglandins Other Lipid Mediat. 2015 Jan-Mar;116-117:26-36. doi: 10.1016/j.prostaglandins.2014.10.002. Epub 2014 Oct 22.

20.

Loss of the polycomb mark from bivalent promoters leads to activation of cancer-promoting genes in colorectal tumors.

Hahn MA, Li AX, Wu X, Yang R, Drew DA, Rosenberg DW, Pfeifer GP.

Cancer Res. 2014 Jul 1;74(13):3617-3629. doi: 10.1158/0008-5472.CAN-13-3147. Epub 2014 May 1.

21.

HD chromoendoscopy coupled with DNA mass spectrometry profiling identifies somatic mutations in microdissected human proximal aberrant crypt foci.

Drew DA, Devers TJ, O'Brien MJ, Horelik NA, Levine J, Rosenberg DW.

Mol Cancer Res. 2014 Jun;12(6):823-9. doi: 10.1158/1541-7786.MCR-13-0624. Epub 2014 Mar 20.

22.

Suppression of colon carcinogenesis by targeting Notch signaling.

Miyamoto S, Nakanishi M, Rosenberg DW.

Carcinogenesis. 2013 Oct;34(10):2415-23. doi: 10.1093/carcin/bgt191. Epub 2013 Jun 1.

23.

Nanoproteomic analysis of extracellular receptor kinase-1/2 post-translational activation in microdissected human hyperplastic colon lesions.

Drew DA, Devers T, Horelik N, Yang S, O'Brien M, Wu R, Rosenberg DW.

Proteomics. 2013 May;13(9):1428-36. doi: 10.1002/pmic.201200430. Epub 2013 Apr 4.

24.

Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53.

Morad SA, Madigan JP, Levin JC, Abdelmageed N, Karimi R, Rosenberg DW, Kester M, Shanmugavelandy SS, Cabot MC.

Biochem Pharmacol. 2013 Apr 15;85(8):1057-65. doi: 10.1016/j.bcp.2013.01.015. Epub 2013 Jan 24.

25.

Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.

Ménoret A, Drew DA, Miyamoto S, Nakanishi M, Vella AT, Rosenberg DW.

Mol Carcinog. 2014 Feb;53 Suppl 1:E11-22. doi: 10.1002/mc.21986. Epub 2012 Dec 19.

PMID:
23255428
26.

Multifaceted roles of PGE2 in inflammation and cancer.

Nakanishi M, Rosenberg DW.

Semin Immunopathol. 2013 Mar;35(2):123-37. doi: 10.1007/s00281-012-0342-8. Epub 2012 Sep 21. Review.

27.

Dietary methyl donor depletion protects against intestinal tumorigenesis in Apc(Min/+) mice.

Kadaveru K, Protiva P, Greenspan EJ, Kim YI, Rosenberg DW.

Cancer Prev Res (Phila). 2012 Jul;5(7):911-20. doi: 10.1158/1940-6207.CAPR-11-0544. Epub 2012 Jun 7.

28.

Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy.

Anderson JC, Swede H, Rustagi T, Protiva P, Pleau D, Brenner BM, Rajan TV, Heinen CD, Levine JB, Rosenberg DW.

Cancer Causes Control. 2012 Feb;23(2):355-61. doi: 10.1007/s10552-011-9884-7. Epub 2011 Dec 21.

PMID:
22187142
29.

Vitamin D resistance and colon cancer prevention.

Giardina C, Madigan JP, Tierney CA, Brenner BM, Rosenberg DW.

Carcinogenesis. 2012 Mar;33(3):475-82. doi: 10.1093/carcin/bgr301. Epub 2011 Dec 16. Review.

30.

Role of Notch signaling in colon homeostasis and carcinogenesis.

Miyamoto S, Rosenberg DW.

Cancer Sci. 2011 Nov;102(11):1938-42. doi: 10.1111/j.1349-7006.2011.02049.x. Epub 2011 Sep 6. Review.

31.

Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity.

Nakanishi M, Menoret A, Tanaka T, Miyamoto S, Montrose DC, Vella AT, Rosenberg DW.

Cancer Prev Res (Phila). 2011 Aug;4(8):1198-208. doi: 10.1158/1940-6207.CAPR-11-0188. Epub 2011 May 16.

32.

Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells.

Rigatti MJ, Verma R, Belinsky GS, Rosenberg DW, Giardina C.

Mol Carcinog. 2012 May;51(5):363-78. doi: 10.1002/mc.20795. Epub 2011 May 6.

33.

Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}.

Greenspan EJ, Madigan JP, Boardman LA, Rosenberg DW.

Cancer Prev Res (Phila). 2011 Jan;4(1):161-71. doi: 10.1158/1940-6207.CAPR-10-0021.

34.

Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitis.

Montrose DC, Horelik NA, Madigan JP, Stoner GD, Wang LS, Bruno RS, Park HJ, Giardina C, Rosenberg DW.

Carcinogenesis. 2011 Mar;32(3):343-50. doi: 10.1093/carcin/bgq248. Epub 2010 Nov 23.

35.

Intestinal lineage commitment of embryonic stem cells.

Cao L, Gibson JD, Miyamoto S, Sail V, Verma R, Rosenberg DW, Nelson CE, Giardina C.

Differentiation. 2011 Jan;81(1):1-10. doi: 10.1016/j.diff.2010.09.182. Epub 2010 Oct 8.

PMID:
20934799
36.

Molecular alterations associated with sulindac-resistant colon tumors in ApcMin/+ mice.

Greenspan EJ, Nichols FC, Rosenberg DW.

Cancer Prev Res (Phila). 2010 Sep;3(9):1187-97. doi: 10.1158/1940-6207.CAPR-09-0270. Epub 2010 Aug 17.

37.

Colorectal cancer.

Rosenberg DW.

Mutat Res. 2010 Nov 10;693(1-2):1-2. doi: 10.1016/j.mrfmmm.2010.06.012. Epub 2010 Jun 25. No abstract available.

PMID:
20599550
38.

cPLA2 is protective against COX inhibitor-induced intestinal damage.

Montrose DC, Kadaveru K, Ilsley JN, Root SH, Rajan TV, Ramesh M, Nichols FC, Liang BT, Sonin D, Hand AR, Zarini S, Murphy RC, Belinsky GS, Nakanishi M, Rosenberg DW.

Toxicol Sci. 2010 Sep;117(1):122-32. doi: 10.1093/toxsci/kfq184. Epub 2010 Jun 18.

39.

CD13 is dispensable for normal hematopoiesis and myeloid cell functions in the mouse.

Winnicka B, O'Conor C, Schacke W, Vernier K, Grant CL, Fenteany FH, Pereira FE, Liang B, Kaur A, Zhao R, Montrose DC, Rosenberg DW, Aguila HL, Shapiro LH.

J Leukoc Biol. 2010 Aug;88(2):347-59. doi: 10.1189/jlb.0210065. Epub 2010 Apr 29.

40.

Chlorogenic acid differentially alters hepatic and small intestinal thiol redox status without protecting against azoxymethane-induced colon carcinogenesis in mice.

Park HJ, Davis SR, Liang HY, Rosenberg DW, Bruno RS.

Nutr Cancer. 2010;62(3):362-70. doi: 10.1080/01635580903407239.

PMID:
20358474
41.

Increased frequency of serrated aberrant crypt foci among smokers.

Anderson JC, Pleau DC, Rajan TV, Protiva P, Swede H, Brenner B, Heinen CD, Lambrecht RW, Rosenberg DW.

Am J Gastroenterol. 2010 Jul;105(7):1648-54. doi: 10.1038/ajg.2010.109. Epub 2010 Mar 16.

PMID:
20234347
42.

mPGES-1 as a target for cancer suppression: A comprehensive invited review "Phospholipase A2 and lipid mediators".

Nakanishi M, Gokhale V, Meuillet EJ, Rosenberg DW.

Biochimie. 2010 Jun;92(6):660-4. doi: 10.1016/j.biochi.2010.02.006. Epub 2010 Feb 13. Review.

43.

Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "Aberrant crypt foci in the adenoma prevention with celecoxib trial".

Stevens RG, Pretlow TP, Hurlstone DP, Giardina C, Rosenberg DW.

Cancer Prev Res (Phila). 2008 Aug;1(3):215-6; author reply 216. doi: 10.1158/1940-6207.CAPR-08-0094. No abstract available.

44.

Number of aberrant crypt foci associated with adiposity and IGF1 bioavailability.

Swede H, Rohan TE, Yu H, Anderson JC, Stevens RG, Brokaw J, Levine J, Brenner BM, Malchoff CD, Duffy VB, Pleau DC, Rosenberg DW.

Cancer Causes Control. 2009 Jul;20(5):653-61. doi: 10.1007/s10552-008-9278-7. Epub 2008 Dec 9.

45.

Mouse models for the study of colon carcinogenesis.

Rosenberg DW, Giardina C, Tanaka T.

Carcinogenesis. 2009 Feb;30(2):183-96. doi: 10.1093/carcin/bgn267. Epub 2008 Nov 26. Review.

46.

The short chain fatty acid butyrate induces promoter demethylation and reactivation of RARbeta2 in colon cancer cells.

Spurling CC, Suhl JA, Boucher N, Nelson CE, Rosenberg DW, Giardina C.

Nutr Cancer. 2008;60(5):692-702. doi: 10.1080/01635580802008278.

PMID:
18791934
47.

Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression.

Al-Salihi MA, Terrece Pearman A, Doan T, Reichert EC, Rosenberg DW, Prescott SM, Stafforini DM, Topham MK.

Cancer Lett. 2009 Jan 18;273(2):225-32. doi: 10.1016/j.canlet.2008.08.012. Epub 2008 Sep 14.

48.

HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling.

Godman CA, Joshi R, Tierney BR, Greenspan E, Rasmussen TP, Wang HW, Shin DG, Rosenberg DW, Giardina C.

Cancer Biol Ther. 2008 Oct;7(10):1570-80. Epub 2008 Oct 7.

49.

Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis.

Nakanishi M, Montrose DC, Clark P, Nambiar PR, Belinsky GS, Claffey KP, Xu D, Rosenberg DW.

Cancer Res. 2008 May 1;68(9):3251-9. doi: 10.1158/0008-5472.CAN-07-6100.

50.

Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate.

Mounier CM, Wendum D, Greenspan E, Fléjou JF, Rosenberg DW, Lambeau G.

Br J Cancer. 2008 Feb 12;98(3):587-95. doi: 10.1038/sj.bjc.6604184. Epub 2008 Jan 22.

Supplemental Content

Loading ...
Support Center